General Info

Dr. Locke is the founder and director of the Vantage Urologic Institute located in Ocala, Florida. His specialty interests are in urologic oncology (cancer), minimally invasive therapies for prostate disease, and male sexual health. Dr. Locke is certified by the American Board of Urology and is a Fellow of the American College of Surgeons. He is an active member of many regional and national healthcare organizations, including the American Urological Association, the Southeastern Section of the AUA, and the Florida Urological Society. He frequently speaks at community and industry-sponsored events on his clinical and professional interests. Dr. Locke has vast experience in clinical research, especially in prostate cancer. His urological expertise is in prostate cancer diagnosis and stratification, structured active surveillance (delayed intervention) for patients with low-risk prostate cancer, noninvasive focal ablation therapies for small localized prostate tumors, new and emerging therapies for advanced prostate cancer, and male sexual health and vitality.